964 01/01/2023 31/12/2023 2023-12-31 false false false false true false false false false false true false false true false false false false false true false No description of principal activities is disclosed 2023-01-01 Sage Accounts Production 23.0 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP NI058361 2023-01-01 2023-12-31 NI058361 2023-12-31 NI058361 2022-12-31 NI058361 2022-01-01 2022-12-31 NI058361 2022-12-31 NI058361 2021-12-31 NI058361 core:FurnitureFittingsToolsEquipment 2023-01-01 2023-12-31 NI058361 core:MotorVehicles 2023-01-01 2023-12-31 NI058361 bus:RegisteredOffice 2023-01-01 2023-12-31 NI058361 bus:OrdinaryShareClass1 2023-01-01 2023-12-31 NI058361 bus:LeadAgentIfApplicable 2023-01-01 2023-12-31 NI058361 bus:Director1 2023-01-01 2023-12-31 NI058361 bus:Director3 2023-01-01 2023-12-31 NI058361 bus:Director4 2023-01-01 2023-12-31 NI058361 bus:Director5 2023-01-01 2023-12-31 NI058361 bus:Director6 2023-01-01 2023-12-31 NI058361 bus:Director7 2023-01-01 2023-12-31 NI058361 core:WithinOneYear 2023-12-31 NI058361 core:WithinOneYear 2022-12-31 NI058361 core:FurnitureFittingsToolsEquipment 2022-12-31 NI058361 core:MotorVehicles 2022-12-31 NI058361 core:FurnitureFittingsToolsEquipment 2023-12-31 NI058361 core:MotorVehicles 2023-12-31 NI058361 core:DeferredTaxation 2023-01-01 2023-12-31 NI058361 core:RetainedEarningsAccumulatedLosses 2022-01-01 2022-12-31 NI058361 core:RetainedEarningsAccumulatedLosses 2023-01-01 2023-12-31 NI058361 core:AfterOneYear 2023-12-31 NI058361 core:AfterOneYear 2022-12-31 NI058361 core:UKTax 2023-01-01 2023-12-31 NI058361 core:UKTax 2022-01-01 2022-12-31 NI058361 core:ShareCapital 2023-12-31 NI058361 core:ShareCapital 2022-12-31 NI058361 core:RetainedEarningsAccumulatedLosses 2023-12-31 NI058361 core:RetainedEarningsAccumulatedLosses 2022-12-31 NI058361 core:ShareCapital 2021-12-31 NI058361 core:RetainedEarningsAccumulatedLosses 2021-12-31 NI058361 core:PreviouslyStatedAmount core:ShareCapital 2023-12-31 NI058361 bus:OrdinaryShareClass1 core:ShareCapital 2023-12-31 NI058361 bus:OrdinaryShareClass1 core:ShareCapital 2022-12-31 NI058361 core:BetweenOneFiveYears 2023-12-31 NI058361 core:BetweenOneFiveYears 2022-12-31 NI058361 core:AcceleratedTaxDepreciationDeferredTax 2023-12-31 NI058361 core:AcceleratedTaxDepreciationDeferredTax 2022-12-31 NI058361 core:FurnitureFittingsToolsEquipment 2022-12-31 NI058361 core:MotorVehicles 2022-12-31 NI058361 core:DeferredTaxation 2022-12-31 NI058361 core:DeferredTaxation 2023-12-31 NI058361 bus:MediumEntities 2023-01-01 2023-12-31 NI058361 bus:Audited 2023-01-01 2023-12-31 NI058361 bus:Medium-sizedCompaniesRegimeForAccounts 2023-01-01 2023-12-31 NI058361 bus:PrivateLimitedCompanyLtd 2023-01-01 2023-12-31 NI058361 bus:FullAccounts 2023-01-01 2023-12-31 NI058361 core:AfterOneYear 2023-01-01 2023-12-31
Company registration number: NI058361
Connected Health Domiciliary Care Limited
Financial statements
31 December 2023
Connected Health Domiciliary Care Limited
Contents
Directors and other information
Strategic report
Directors report
Independent auditor's report to the members
Statement of comprehensive income
Statement of financial position
Statement of changes in equity
Statement of cash flows
Notes to the financial statements
Connected Health Domiciliary Care Limited
Directors and other information
Directors Douglas Adams
Robin Horner
Kevin Lagan
Brian O'Connor
Robert Notley
Ryan Williams
Company number NI058361
Registered office 3B Boucher Business Studios
Glenmachan Place
Belfast
BT12 6QH
Auditor Hill Vellacott
Chamber of Commerce House
22 Great Victoria Street
Belfast
BT2 7BA
Bankers Ulster Bank
11 - 16 Donegall Square East
Belfast
BT1 5UB
Connected Health Domiciliary Care Limited
Strategic report
Year ended 31 December 2023
Business review and position
The principal activity of the company is the provision of domiciliary health care services
The directors are satisfied with the company's performance.
The company operates in a very competitive marketplace and the directors have taken steps to ensure that the company will maintain its competitive strengths and are confident of future results.
Given the nature of the company's activities, the directors are of the opinion that the use of key performance indicators is not necessary for an understanding of the development, performance or position of the company.
Financial risk management objectives and policies
The company has exposure to liquidity risk and customer credit exposure. To a lesser extent the company is exposed to interest rate risk.
The objective of the company in managing liquidity risk is to ensure that it can meet its financial obligations as and when they fall due. The company expects to meet its financial obligations through operating cash flows. In the event that the operating cash flows would not cover all the financial obligations the company will seek additional credit facilities. Given the maturity of the bank loans, the company is in position to meet its commitments and obligations as they come due.
The company borrows from its bankers using either overdrafts or term loans whose tenure depends on the nature of the asset and management's view of the future direction of interest rate.
This report was approved by the board of directors on 16 April 2024 and signed on behalf of the board by:
Douglas Adams
Director
Robin Horner
Director
Connected Health Domiciliary Care Limited
Directors report
Year ended 31 December 2023
The directors present their report and the financial statements of the company for the year ended 31 December 2023.
Directors
The directors who served the company during the year were as follows:
Douglas Adams
Robin Horner
Kevin Lagan
Brian O'Connor
Robert Notley
Ryan Williams
Dividends
The directors do not recommend the payment of a dividend.
Future developments
The directors will continue to develop the business and will seek to take advantage of opportunities that arise in the future.
Employment of disabled persons
The directors are committed to the principal of equal opprtunity in employment. Applications for employment by disabled persons are always fully considered, bearing in mind the respective aptitudes and abilities of the applicant concerned. In the event of members of staff becoming disabled every effort is made to ensure that their employment with the company continues and the appropriate training is arranged. It is the policy of the company that the training, career development and promotion of a disabled person should, as far as possible, be identical to that of a person who does not suffer from a diability.
Employee involvement
Consultation with employees or their representative has continued at all levels, with the aim of ensuring that views are not taken into account when decisions are made that are likly to affect their interests. Regular meetings are held between local management and employees to allow a free flow of information and ideas.
Financial instruments
Details of financial instruments are provided in the strategic report on page 2
Directors responsibilities statement
The directors are responsible for preparing the strategic report, directors report and the financial statements in accordance with applicable law and regulations.
Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the profit or loss of the company for that period.
In preparing these financial statements, the directors are required to:
- select suitable accounting policies and then apply them consistently;
- make judgments and accounting estimates that are reasonable and prudent; and
- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company's transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
Auditor
Each of the persons who is a director at the date of approval of this report confirms that:
- so far as they are aware, there is no relevant audit information of which the company's auditor is unaware; and - they have taken all steps that they ought to have taken as a director to make themselves aware of any relevant audit information and to establish that the company's auditor is aware of that information.
The auditor is deemed to have been re-appointed in accordance with section 487 of the Companies Act 2006.
This report was approved by the board of directors on 16 April 2024 and signed on behalf of the board by:
Douglas Adams Robin Horner
Director Director
Independent auditor's report to the members of
Connected Health Domiciliary Care Limited
Year ended 31 December 2023
Opinion
We have audited the financial statements of Connected Health Domiciliary Care Limited (the 'company') for the year ended 31 December 2023 which comprise the statement of comprehensive income, statement of financial position, statement of changes in equity, statement of cash flows and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice). In our opinion, the financial statements: - give a true and fair view of the state of the company's affairs as at 31 December 2023 and of its profit for the year then ended; - have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and - have been prepared in accordance with the requirements of the Companies Act 2006.
Basis for opinion
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the auditor’s responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
Other Information
The other information comprises the information included in the annual report, other than the financial statements and our auditor’s report thereon. The directors are responsible for the other information. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. In connection with our audit of the financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether there is a material misstatement in the financial statements or a material misstatement of the other information. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact. We have nothing to report in this regard.
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of the audit:
- the information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
- the strategic report and the directors' report has been prepared in accordance with applicable legal requirements.
Matters on which we are required to report by exception
In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report. We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion: - adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or - the financial statements are not in agreement with the accounting records and the returns; or - certain disclosures of directors' remuneration specified by law are not made; or - we have not received all the information and explanations we require for our audit.
Responsibilities of directors
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.
Auditor's responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements. Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below: Our approach was as follows: We obtained an understanding of the legal and regulatory frameworks that are applicable to the entity and determined that the most significant are those that relate to the Companies Act 2006 and compliance with FRS102 and laws and regulations concerned with UK government COVID-19 support schemes; and we assessed the risks of material misstatement in respect of fraud with the consideration of the company's own assessment of the risks that irregularities may occur either because of fraud or error; the results of our enquiries of management about their own identification and assessment of the risks of irregularities; any matters we identified having obtained and reviewed the company's documentation of their policies and procedures relating to identifying, evaluating and complying with laws and regulations and whether they were aware of any instances of non-compliance; detecting and responding to the risks of fraud and whether they have knowledge of any actual, suspected or alleged fraud; the internal controls established to mitigate risks of fraud or non-compliance with laws and regulations; and the matters discussed among the audit engagement team regarding how and where fraud might occur in the financial statements and any potential indicators of fraud. Based on the results of our risk assessment we designed our audit procedures to identify non-compliance with such laws and regulations identified above, we considered the opportunities and incentives that may exist within the organisation for fraud and identified the greatest potential for fraud in the areas in which management is required to exercise significant judgment, such as disclosure of adjusting items. In common with all audits under ISAs (UK), we are also required to perform specific procedures to respond to the risk of management override; we also obtained an understanding of the legal and regulatory framework that the company operates in, focusing on provisions of those laws and regulations that had a direct effect on the determination of material amounts and disclosures in the financial statements. The key laws and regulations we considered in this context included UK Companies Act and tax legislation; and in addition, we considered provisions of other laws and regulations that do not have a direct effect on the financial statements but compliance with which may be fundamental to the company's ability to operate or to avoid a material penalty. These included data protection, employment and health and safety regulations. Audit procedures designed to respond to the risks of fraud: We considered the risk of fraud through management override and, in response, we incorporated testing of manual journal entries into our audit approach. We considered the risk of fraud through transactions outside the normal course of transactions by noting anything that was unusual in nature or size and enquired about such transaction to gain an understanding of their nature; based on the results of our risk assessment we designed our audit procedures to identify and to address material misstatements in relation to fraud and other irregularities; extent of audit procedures; and we evaluated the selection and application of accounting policies by the company, particularly those related to subjective measurements and complex transactions, that may be indicative of fraudulent financial reporting. A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor’s report.
Use of our report
This report is made solely to the company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's members those matters we are required to state to them in an auditors report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's members as a body, for our audit work, for this report, or for the opinions we have formed.
Eoin McMullan, ACA (Senior Statutory Auditor)
For and on behalf of
Hill Vellacott
Chartered Accountants
Chamber of Commerce House
22 Great Victoria Street
Belfast
BT2 7BA
16 April 2024
Connected Health Domiciliary Care Limited
Statement of comprehensive income
Year ended 31 December 2023
2023 2022
Note £ £
Turnover 4 21,064,653 20,431,270
Cost of sales ( 16,573,938) ( 16,493,226)
_______ _______
Gross profit 4,490,715 3,938,044
Administrative expenses ( 1,726,665) ( 1,071,254)
_______ _______
Operating profit 5 2,764,050 2,866,790
Interest payable and similar expenses 7 ( 26,926) ( 23,417)
Profit before taxation 2,737,124 2,843,373
Tax on profit 8 ( 187,525) ( 125,550)
_______ _______
Profit for the financial year 2,549,599 2,717,823
_______ _______
User defined other comprehensive income movement 1 - (97,732)
_______ _______
Total comprehensive income for the year 2,549,599 2,620,091
_______ _______
All the activities of the company are from continuing operations.
Connected Health Domiciliary Care Limited
Statement of financial position
31 December 2023
2023 2022
Note £ £ £ £
Fixed assets
Tangible assets 9 329,912 190,476
_______ _______
329,912 190,476
Current assets
Debtors 10 16,185,286 13,819,883
Cash at bank and in hand 195,347 849,556
_______ _______
16,380,633 14,669,439
Creditors: amounts falling due
within one year 12 ( 1,806,204) ( 2,598,530)
_______ _______
Net current assets 14,574,429 12,070,909
_______ _______
Total assets less current liabilities 14,904,341 12,261,385
Creditors: amounts falling due
after more than one year 13 ( 163,749) ( 76,925)
Provisions for liabilities 15 ( 19,814) ( 13,281)
_______ _______
Net assets 14,720,778 12,171,179
_______ _______
Capital and reserves
Called up share capital 18 300 300
Profit and loss account 19 14,720,478 12,170,879
_______ _______
Shareholders funds 14,720,778 12,171,179
_______ _______
These financial statements were approved by the board of directors and authorised for issue on 16 April 2024 , and are signed on behalf of the board by:
Douglas Adams Robin Horner
Director Director
Company registration number: NI058361
Connected Health Domiciliary Care Limited
Statement of changes in equity
Year ended 31 December 2023
Called up share capital Profit and loss account Total
£ £ £
At 1 January 2022 300 9,550,788 9,551,088
Profit for the year 2,717,823 2,717,823
Other comprehensive income for the year:
User defined other comprehensive income movement 1 - (97,732) (97,732)
_______ _______ _______
Total comprehensive income for the year - 2,620,091 2,620,091
_______ _______ _______
At 31 December 2022 and 1 January 2023 300 12,170,879 12,171,179
Profit for the year 2,549,599 2,549,599
_______ _______ _______
Total comprehensive income for the year - 2,549,599 2,549,599
_______ _______ _______
At 31 December 2023 300 14,720,478 14,720,778
_______ _______ _______
Connected Health Domiciliary Care Limited
Statement of cash flows
Year ended 31 December 2023
2023 2022
Note £ £
Cash flows from operating activities
Profit for the financial year 2,549,599 2,717,823
Adjustments for:
Depreciation of tangible assets 81,320 91,191
Interest payable and similar expenses 26,926 23,417
Tax on profit 187,525 125,550
Accrued expenses/(income) 83,370 155,765
Changes in:
Trade and other debtors ( 2,365,403) ( 2,104,439)
Trade and other creditors ( 515,360) ( 290,805)
Exectional items expenses - (142,769)
_______ _______
Cash generated from operations 47,977 575,733
Interest paid ( 26,926) ( 23,417)
Tax paid ( 551,768) ( 219,847)
_______ _______
Net cash (used in)/from operating activities ( 530,717) 332,469
_______ _______
Cash flows from investing activities
Purchase of tangible assets ( 232,785) ( 134,680)
Proceeds from sale of tangible assets 12,029 -
_______ _______
Net cash used in investing activities ( 220,756) ( 134,680)
_______ _______
Cash flows from financing activities
Proceeds from borrowings ( 62,713) ( 362,960)
Proceeds from loans from group undertakings 478,875 -
Payment of finance lease liabilities 94,724 140,426
_______ _______
Net cash from/(used in) financing activities 510,886 ( 222,534)
_______ _______
Net increase/(decrease) in cash and cash equivalents ( 240,587) ( 24,745)
Cash and cash equivalents at beginning of year 11 547,790 572,535
_______ _______
Cash and cash equivalents at end of year 11 307,203 547,790
_______ _______
Connected Health Domiciliary Care Limited
Notes to the financial statements
Year ended 31 December 2023
1. General information
The company is a private company limited by shares, registered in Northern Ireland. The address of the registered office is 3B Boucher Business Studios, Glenmachan Place, Belfast, BT12 6QH.
2. Statement of compliance
These financial statements have been prepared in compliance with FRS 102, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances. Significant judgementsThere are no judgments (apart from those involving estimations) that management has made in the process of applying the entity's accounting policies and that have the most significant effect on the amounts recognised in the financial statements.Key sources of estimation uncertaintyAccounting estimates and assumptions are made concerning the future and, by their nature, will rarely equal the related actual outcome. The key assumptions and other sources of estimation uncertainty that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are as follows: Impairment of trade debtors is reviewed on an ongoing basis. The company uses estimatesbased on historical experience and current information in determining the debts for which animpairment charge is required.
Turnover
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for services rendered, stated net of discounts.When the outcome of a transaction involving the rendering of services can be reliably estimated, revenue from the rendering of services is measured by reference to the stage of completion of the service transaction at the end of the reporting period.When the outcome of a transaction involving the rendering of services cannot be reliably estimated, revenue is recognised only to the extent that expenses recognised are recoverable.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Foreign currencies
Foreign currency transactions are initially recorded in the functional currency, by applying the spot exchange rate as at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the exchange rate ruling at the reporting date, with any gains or losses being taken to profit or loss.
Tangible assets
tangible assets are initially recorded at cost, and are subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in capital and reserves, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in capital and reserves in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in capital and reserves in respect of that asset, the excess shall be recognised in profit or loss.
Depreciation
Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:
Fittings fixtures and equipment - 25 % straight line
Motor vehicles - 20 % straight line
If there is an indication that there has been a significant change in depreciation rate, useful life or residual value of tangible assets, the depreciation is revised prospectively to reflect the new estimates.
Impairment
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. When it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that are largely independent of the cash inflows from other assets or groups of assets.
Hire purchase and finance leases
Assets held under finance leases are recognised in the statement of financial position as assets and liabilities at the lower of the fair value of the assets and the present value of the minimum lease payments, which is determined at the inception of the lease term. Any initial direct costs of the lease are added to the amount recognised as an asset. Lease payments are apportioned between the finance charges and reduction of the outstanding lease liability using the effective interest method. Finance charges are allocated to each period so as to produce a constant rate of interest on the remaining balance of the liability.
Provisions
Provisions are recognised when the entity has an obligation at the reporting date as a result of a past event; it is probable that the entity will be required to transfer economic benefits in settlement and the amount of the obligation can be estimated reliably. Provisions are recognised as a liability in the statement of financial position and the amount of the provision as an expense. Provisions are initially measured at the best estimate of the amount required to settle the obligation at the reporting date and subsequently reviewed at each reporting date and adjusted to reflect the current best estimate of the amount that would be required to settle the obligation. Any adjustments to the amounts previously recognised are recognised in profit or loss unless the provision was originally recognised as part of the cost of an asset. When a provision is measured at the present value of the amount expected to be required to settle the obligation, the unwinding of the discount is recognised in finance costs in profit or loss in the period it arises.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.
Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.
Defined contribution plans
Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund.When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.
4. Turnover
Turnover arises from:
2023 2022
£ £
Rendering of services 21,064,653 20,431,270
_______ _______
The whole of the turnover is attributable to the principal activity of the company wholly undertaken in the United Kingdom.
5. Operating profit
Operating profit is stated after charging/(crediting):
2023 2022
£ £
Depreciation of tangible assets 81,320 91,191
Impairment of trade debtors - 69,252
Foreign exchange differences - ( 11,720)
Fees payable for the audit of the financial statements 27,640 13,700
_______ _______
6. Staff costs
The average number of persons employed by the company during the year, including the directors, amounted to:
2023 2022
Administrative staff 77 37
Direct cost care staff 887 770
_______ _______
964 807
_______ _______
The aggregate payroll costs incurred during the year were:
2023 2022
£ £
Wages and salaries 16,027,679 15,189,022
Social security costs 1,017,929 1,065,264
Other pension costs 227,943 220,698
_______ _______
17,273,551 16,474,984
_______ _______
7. Interest payable and similar expenses
2023 2022
£ £
Bank loans and overdrafts 4,942 23,417
Other loans made to the company:
Finance leases and hire purchase contracts 18,254 -
Other interest payable and similar expenses 3,730 -
_______ _______
26,926 23,417
_______ _______
8. Tax on profit
Major components of tax expense
2023 2022
£ £
Current tax:
UK current tax expense 88,636 115,609
Adjustments in respect of previous periods 92,356 -
_______ _______
Deferred tax:
Origination and reversal of timing differences 6,533 9,941
_______ _______
Tax on profit 187,525 125,550
_______ _______
Reconciliation of tax expense
The tax assessed on the profit for the year is lower than (2022: lower than) the standard rate of corporation tax in the UK of 25.00 % (2022: 19.00%).
2023 2022
£ £
Profit before taxation 2,737,124 2,843,373
_______ _______
Profit multiplied by rate of tax 684,281 540,241
Adjustments in respect of prior periods 92,356 -
Effect of expenses not deductible for tax purposes 11,081 ( 12,876)
Effect of capital allowances and depreciation 10,274 22,932
Effect of different UK tax rates on some earnings (7,426) -
Group relief ( 603,041) ( 424,747)
_______ _______
Tax on profit 187,525 125,550
_______ _______
9. Tangible assets
Fixtures, fittings and equipment Motor vehicles Total
£ £ £
Cost
At 1 January 2023 153,109 252,761 405,870
Additions 24,350 208,435 232,785
Disposals - ( 15,995) ( 15,995)
_______ _______ _______
At 31 December 2023 177,459 445,201 622,660
_______ _______ _______
Depreciation
At 1 January 2023 129,655 85,739 215,394
Charge for the year 8,624 72,696 81,320
Disposals - ( 3,966) ( 3,966)
_______ _______ _______
At 31 December 2023 138,279 154,469 292,748
_______ _______ _______
Carrying amount
At 31 December 2023 39,180 290,732 329,912
_______ _______ _______
At 31 December 2022 23,454 167,022 190,476
_______ _______ _______
10. Debtors
2023 2022
£ £
Trade debtors 3,040,784 2,315,146
Amounts owed by group undertakings 13,031,156 10,666,993
Prepayments and accrued income 121,471 87,838
Other debtors ( 8,125) 749,906
_______ _______
16,185,286 13,819,883
_______ _______
11. Cash and cash equivalents
2023 2022
£ £
Cash at bank and in hand 195,347 849,556
Bank overdrafts 111,856 ( 301,766)
_______ _______
307,203 547,790
_______ _______
12. Creditors: amounts falling due within one year
2023 2022
£ £
Bank loans and overdrafts ( 111,856) 364,479
Trade creditors 152,676 62,302
Amounts owed to group undertakings 478,875 -
Accruals and deferred income 681,247 597,877
Corporation tax 88,636 459,412
Social security and other taxes 308,218 1,007,720
Obligations under finance leases 71,401 63,501
Other creditors 137,007 43,239
_______ _______
1,806,204 2,598,530
_______ _______
13. Creditors: amounts falling due after more than one year
2023 2022
£ £
Obligations under finance leases 163,749 76,925
_______ _______
The bank has a fixed and floating charge over the assets of the company in respect of the total short and long term loan amounts. These are supported by cross guarantees with Connected Health Limited, Home Care Plus Limited and IBBSOL Ltd .
14. Obligations under finance leases
Company lessee
The total future minimum lease payments under finance lease agreements are as follows:
2023 2022
£ £
Not later than 1 year 71,401 63,501
Later than 1 year and not later than 5 years 163,749 76,925
_______ _______
235,150 140,426
_______ _______
Present value of minimum lease payments 235,150 140,426
_______ _______
15. Provisions
Deferred tax (note 16) Total
£ £
At 1 January 2023 13,281 13,281
Additions 6,533 6,533
_______ _______
At 31 December 2023 19,814 19,814
_______ _______
16. Deferred tax
The deferred tax included in the statement of financial position is as follows:
2023 2022
£ £
Included in provisions (note 15) 19,814 13,281
_______ _______
The deferred tax account consists of the tax effect of timing differences in respect of:
2023 2022
£ £
Accelerated capital allowances 19,814 13,281
_______ _______
17. Employee benefits
The amount recognised in profit or loss in relation to defined contribution plans was £ 227,943 (2022: £ 220,698 ).
18. Called up share capital
Issued, called up and fully paid
2023 2022
No £ No £
Ordinary shares shares of £ 0.01 each 30,000 300 30,000 300
_______ _______ _______ _______
19. Reserves
Profit and loss account:This reserve records retained earnings and accumulated losses .
20. Analysis of changes in net debt
At 1 January 2023 Cash flows At 31 December 2023
£ £ £
Cash and cash equivalents 849,556 (654,209) 195,347
Bank overdrafts (301,766) 413,622 111,856
Debt due within one year (126,214) (424,062) (550,276)
Debt due after one year (76,925) (86,824) (163,749)
_______ _______ _______
344,651 ( 751,473) ( 406,822)
_______ _______ _______
21. Operating leases
The company as lessee
The total future minimum lease payments under non-cancellable operating leases are as follows:
£ £
Not later than 1 year 43,615 44,489
Later than 1 year and not later than 5 years 26,740 15,000
_______ _______
70,355 59,489
_______ _______
22. Limitation of auditors liability
The company has entered into a liability limitation agreement with the company's auditor which was approved on 15 February 2024. The principal terms of the agreement are that the auditor's liability is limited to a multiple of the audit fee issued and paid for the year, but the multiple cannot be less than such amount as is fair and reasonable.
23. Related party transactions
The company is a wholly owned subsidiary of Connected Health Limited, along with Home Care Plus Limited and Connected Health (Care NI) Limited.At the balance sheet date the company was owed £13,031,156 (2022: £10,601,918) from Connected Health Limited.At the balance sheet date the company owed £76,736 (2022: £152,112) to Home Care Plus Limited. At the balance sheet date the company owed £478,875 (2022: - £65,075) from Connected Health (Care NI) Limited.
24. Controlling party
Connected Health Limited owns 100% of the share capital in Connected Health Domiciliary Limited.